Friday - March 13, 2026
Goodwin Guides CRISPR Therapeutics on Pricing $550 Million Upsized Convertible Senior Notes Offering
March 12, 2026
BOSTON, Massachusetts, March 12 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

Goodwin Guides CRISPR Therapeutics on Pricing $550 Million Upsized Convertible Senior Notes Offering

*

The Life Sciences and Equity-Linked Capital Markets teams guided CRISPR Therapeutics AG (the "Company") on the pricing of $550 million aggregate principal amount of its convertible senior notes due 2031 (the " . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products